News

New in vitro assays and services

New

New assays currently available in our catalog.

BIOalternatives is now an authorized Affymetrix service provider

Publications and communications

All our current articles and reviews

For decades, cancer was associated with gapjunction defects. However, more recently it appeared that the gap junction proteins(connexins) could be re-expressed and participate to cancer cell dissemination during the late stages of tumor progression.

BIOalternatives, 1 bis rue des plantes 86160 GENCAY - France Tel: +33 (0)549.36.11.37
Fax: +33 (0)549.53.10.29
Contact us
for service and support
BIOalternatives > News